IL275126B - Methods of predicting progression of barrett's esophagus - Google Patents

Methods of predicting progression of barrett's esophagus

Info

Publication number
IL275126B
IL275126B IL275126A IL27512620A IL275126B IL 275126 B IL275126 B IL 275126B IL 275126 A IL275126 A IL 275126A IL 27512620 A IL27512620 A IL 27512620A IL 275126 B IL275126 B IL 275126B
Authority
IL
Israel
Prior art keywords
barrett
esophagus
methods
predicting progression
predicting
Prior art date
Application number
IL275126A
Other languages
Hebrew (he)
Other versions
IL275126A (en
Inventor
J Thorne Rebecca
Original Assignee
Cernostics Inc
J Thorne Rebecca
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cernostics Inc, J Thorne Rebecca filed Critical Cernostics Inc
Publication of IL275126A publication Critical patent/IL275126A/en
Publication of IL275126B publication Critical patent/IL275126B/en

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57484—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/52—Use of compounds or compositions for colorimetric, spectrophotometric or fluorometric investigation, e.g. use of reagent paper and including single- and multilayer analytical elements
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407—Specifically defined cancers
    • G01N33/57446—Specifically defined cancers of stomach or intestine
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/56—Staging of a disease; Further complications associated with the disease
IL275126A 2015-11-25 2020-06-04 Methods of predicting progression of barrett's esophagus IL275126B (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201562260010P 2015-11-25 2015-11-25
PCT/US2016/063482 WO2017091658A1 (en) 2015-11-25 2016-11-23 Methods of predicting progression of barrett's esophagus

Publications (2)

Publication Number Publication Date
IL275126A IL275126A (en) 2020-07-30
IL275126B true IL275126B (en) 2021-05-31

Family

ID=58763606

Family Applications (2)

Application Number Title Priority Date Filing Date
IL259561A IL259561B (en) 2015-11-25 2018-05-23 Methods of predicting progression of barrett's esophagus
IL275126A IL275126B (en) 2015-11-25 2020-06-04 Methods of predicting progression of barrett's esophagus

Family Applications Before (1)

Application Number Title Priority Date Filing Date
IL259561A IL259561B (en) 2015-11-25 2018-05-23 Methods of predicting progression of barrett's esophagus

Country Status (7)

Country Link
US (2) US10962544B2 (en)
EP (3) EP3380840B1 (en)
AU (2) AU2016359685B2 (en)
CA (1) CA3006356A1 (en)
ES (2) ES2931924T3 (en)
IL (2) IL259561B (en)
WO (1) WO2017091658A1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3553527A1 (en) 2011-03-17 2019-10-16 Cernostics, Inc. Systems and compositions for diagnosing barrett's esophagus and methods of using the same
WO2017091658A1 (en) 2015-11-25 2017-06-01 Cernostics, Inc. Methods of predicting progression of barrett's esophagus
WO2024039692A1 (en) * 2022-08-16 2024-02-22 The Regents Of The University Of California Chromosome 9p24 loss and gain predicts resistance and benefit of immune checkpoint inhibitors

Family Cites Families (65)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU1791192A (en) 1991-04-05 1992-11-02 Pattern Recognition Direct data base analysis, forecasting and diagnosis method
US6025128A (en) 1994-09-29 2000-02-15 The University Of Tulsa Prediction of prostate cancer progression by analysis of selected predictive parameters
EP0852004B1 (en) 1995-10-11 2011-01-19 Luminex Corporation Multiplexed analysis of clinical specimens
US5989835A (en) 1997-02-27 1999-11-23 Cellomics, Inc. System for cell-based screening
US6103479A (en) 1996-05-30 2000-08-15 Cellomics, Inc. Miniaturized cell array methods and apparatus for cell-based screening
US6059724A (en) 1997-02-14 2000-05-09 Biosignal, Inc. System for predicting future health
US7117098B1 (en) 1997-02-27 2006-10-03 Cellomics, Inc. Machine-readable storage medium for analyzing distribution of macromolecules between the cell membrane and the cell cytoplasm
US6759206B1 (en) 1997-02-27 2004-07-06 Cellomics, Inc. System for cell-based screening
EP0983498B1 (en) 1997-02-27 2004-05-26 Cellomics, Inc. A system for cell-based screening
US6416959B1 (en) 1997-02-27 2002-07-09 Kenneth Giuliano System for cell-based screening
US7853411B2 (en) 1997-02-27 2010-12-14 Cellomics, Inc. System for cell-based screening
US6727071B1 (en) 1997-02-27 2004-04-27 Cellomics, Inc. System for cell-based screening
US6259807B1 (en) 1997-05-14 2001-07-10 Applied Imaging Corp. Identification of objects of interest using multiple illumination schemes and finding overlap of features in corresponding multiple images
US6324479B1 (en) 1998-05-08 2001-11-27 Rosetta Impharmatics, Inc. Methods of determining protein activity levels using gene expression profiles
US6218122B1 (en) 1998-06-19 2001-04-17 Rosetta Inpharmatics, Inc. Methods of monitoring disease states and therapies using gene expression profiles
IL142636A0 (en) 1998-10-30 2002-03-10 Cellomics Inc A system for cell-based screening
US20030228565A1 (en) 2000-04-26 2003-12-11 Cytokinetics, Inc. Method and apparatus for predictive cellular bioinformatics
WO2000070528A2 (en) 1999-05-14 2000-11-23 Cytokinetics, Inc. Method and apparatus for predictive cellular bioinformatics
US6986993B1 (en) 1999-08-05 2006-01-17 Cellomics, Inc. System for cell-based screening
AU1465801A (en) 1999-11-03 2001-05-14 Oncotech, Inc. Methods for cancer prognosis and diagnosis
AU2001229637A1 (en) 2000-01-21 2001-07-31 Thomas Jefferson University Nipple aspirate fluid specific microarrays
US6763307B2 (en) 2000-03-06 2004-07-13 Bioseek, Inc. Patient classification
EP1268854A4 (en) 2000-03-27 2003-05-02 Univ Jefferson High specificity marker detection
EP1272224A4 (en) 2000-03-31 2004-09-29 Gene Logic Inc Gene expression profiles in esophageal tissue
CA2414626A1 (en) 2000-07-04 2002-01-10 Bioimage A/S A method for extracting quantitative information relating to interactions between cellular components
AU2001294872A1 (en) 2000-09-28 2002-04-08 Cellomics, Inc. Methods and reagents for live-cell gene expression quantification
US8050868B2 (en) 2001-03-26 2011-11-01 Cellomics, Inc. Methods for determining the organization of a cellular component of interest
US7219016B2 (en) 2001-04-20 2007-05-15 Yale University Systems and methods for automated analysis of cells and tissues
US20040043436A1 (en) 2001-09-21 2004-03-04 Antonia Vlahou Biomarkers of transitional cell carcinoma of the bladder
US7274809B2 (en) 2002-08-29 2007-09-25 Perceptronix Medical, Inc. And British Columbia Cancer Agency Computerized methods and systems related to the detection of malignancy-associated changes (MAC) to detect cancer
US7801361B2 (en) 2002-10-15 2010-09-21 Definiens Ag Analyzing pixel data using image, thematic and object layers of a computer-implemented network structure
AU2003291483A1 (en) 2002-11-12 2004-06-03 Becton, Dickinson And Company Diagnosis of sepsis or sirs using biomarker profiles
DE602004030220D1 (en) 2003-02-27 2011-01-05 Veridex Llc CIRCULATING TUMOR CELLS (CTCs): EARLY ASSESSMENT OF TIME-TO-PROGRESSION, SURVIVAL AND RESPONSE TO THERAPY IN PATIENTS WITH METASTASED CANCER
EP1625394A4 (en) 2003-04-23 2008-02-06 Bioseek Inc Methods for analysis of biological dataset profiles
US7483554B2 (en) 2003-11-17 2009-01-27 Aureon Laboratories, Inc. Pathological tissue mapping
US7461048B2 (en) 2003-07-21 2008-12-02 Aureon Laboratories, Inc. Systems and methods for treating, diagnosing and predicting the occurrence of a medical condition
US7505948B2 (en) 2003-11-18 2009-03-17 Aureon Laboratories, Inc. Support vector regression for censored data
US20050136509A1 (en) 2003-09-10 2005-06-23 Bioimagene, Inc. Method and system for quantitatively analyzing biological samples
US7760927B2 (en) 2003-09-10 2010-07-20 Bioimagene, Inc. Method and system for digital image based tissue independent simultaneous nucleus cytoplasm and membrane quantitation
EP1728211A2 (en) 2004-03-12 2006-12-06 Aureon Laboratories, Inc. Systems and methods for treating, diagnosing and predicting the occurrence of a medical condition
US7761240B2 (en) 2004-08-11 2010-07-20 Aureon Laboratories, Inc. Systems and methods for automated diagnosis and grading of tissue images
US7899623B2 (en) 2004-09-22 2011-03-01 Tripath Imaging, Inc. Methods and computer program products for analysis and optimization of marker candidates for cancer prognosis
EP1645881A1 (en) 2004-10-05 2006-04-12 DKFZ Deutsches Krebsforschungszentrum Screening process for the detection and characterization of protein-protein-interactions in vivo by fluorescence cross correlation spectroscopy
US20060159325A1 (en) 2005-01-18 2006-07-20 Trestle Corporation System and method for review in studies including toxicity and risk assessment studies
US7537894B2 (en) 2005-03-02 2009-05-26 The University Of Chicago Methods and kits for monitoring Barrett's metaplasia
US20070019854A1 (en) 2005-05-10 2007-01-25 Bioimagene, Inc. Method and system for automated digital image analysis of prostrate neoplasms using morphologic patterns
US7599893B2 (en) 2005-10-13 2009-10-06 Aureon Laboratories, Inc. Methods and systems for feature selection in machine learning based on feature contribution and model fitness
GB0521521D0 (en) 2005-10-21 2005-11-30 Medical Res Council Diagnostic methods and kits
GB2433986A (en) 2006-01-09 2007-07-11 Cytokinetics Inc Granularity analysis in cellular phenotypes
EP1984737A2 (en) 2006-01-17 2008-10-29 Cellumen, Inc. Method for predicting biological systems responses
US20070212721A1 (en) 2006-01-27 2007-09-13 Tripath Imaging, Inc. Methods for identifying patients with an increased likelihood of having ovarian cancer and compositions therefor
WO2007089911A2 (en) 2006-01-30 2007-08-09 The Scripps Research Institute Methods for detection of circulating tumor cells and methods of diagnosis of cancer in a mammalian subject
AU2007248424B2 (en) 2006-05-05 2013-04-18 Historx, Inc. Immunohistochemical methods for determining signal transduction activity in tumors
JP5406019B2 (en) 2006-05-17 2014-02-05 セルーメン、インコーポレイテッド Method for automated tissue analysis
US7706591B2 (en) 2006-07-13 2010-04-27 Cellomics, Inc. Neuronal profiling
US7811778B2 (en) 2006-09-06 2010-10-12 Vanderbilt University Methods of screening for gastrointestinal cancer
EP2095119A2 (en) 2006-11-10 2009-09-02 Cellumen, Inc. Protein-protein interaction biosensors and methods of use thereof
US9758833B2 (en) 2008-02-19 2017-09-12 The Johns Hopkins University Methods for predicting esophageal adenocarcinoma (EAC)
CA2759393A1 (en) 2009-04-18 2010-10-21 The Regents Of The University Of Michigan Targeted detection of dysplasia in barrett's esophagus with a novel fluorescence-labeled polypeptide
CA2787027A1 (en) 2010-01-13 2011-07-21 Caris Life Sciences Luxembourg Holdings, S.A.R.L. Detection of gastrointestinal disorders
AU2011237669B2 (en) 2010-04-06 2016-09-08 Caris Life Sciences Switzerland Holdings Gmbh Circulating biomarkers for disease
CA2808417A1 (en) * 2010-08-18 2012-02-23 Caris Life Sciences Luxembourg Holdings, S.A.R.L. Circulating biomarkers for disease
EP3553527A1 (en) * 2011-03-17 2019-10-16 Cernostics, Inc. Systems and compositions for diagnosing barrett's esophagus and methods of using the same
ES2650230T3 (en) * 2011-09-23 2018-01-17 Academisch Medisch Centrum Materials and methods for prognosis of evolution of Barrett's esophagus
WO2017091658A1 (en) 2015-11-25 2017-06-01 Cernostics, Inc. Methods of predicting progression of barrett's esophagus

Also Published As

Publication number Publication date
AU2023200590A1 (en) 2023-03-09
EP3380840A1 (en) 2018-10-03
EP3786640A1 (en) 2021-03-03
ES2931924T3 (en) 2023-01-04
AU2016359685B2 (en) 2022-12-22
IL259561B (en) 2020-06-30
EP3786640B1 (en) 2022-08-24
US20220034894A1 (en) 2022-02-03
EP3380840B1 (en) 2020-08-19
EP3380840A4 (en) 2019-06-26
US20180348226A1 (en) 2018-12-06
IL259561A (en) 2018-07-31
US10962544B2 (en) 2021-03-30
IL275126A (en) 2020-07-30
WO2017091658A1 (en) 2017-06-01
EP4152001A1 (en) 2023-03-22
AU2016359685A1 (en) 2018-06-14
ES2831754T3 (en) 2021-06-09
CA3006356A1 (en) 2017-06-01

Similar Documents

Publication Publication Date Title
AU365268S (en) Pendant
AU363638S (en) Pendant
IL257026A (en) Solid state forms of eluxadoline
HK1248069A1 (en) Desacetoxytubulysin h and analogs thereof
IL285882A (en) Therapeutic uses of l-4-chlorokynurenine
ZA201706282B (en) Solid forms of menaquinols
PL3329145T3 (en) Belt or belt segment
GB201604627D0 (en) Improved method of FT-IMS
IL275126B (en) Methods of predicting progression of barrett's esophagus
GB2536793B (en) Endoscope
HK1257488A1 (en) Formation of bone
GB201522618D0 (en) Methods of screening
GB201512139D0 (en) Methods of treatment
GB201721386D0 (en) Chrondogy of time-wave
GB201712596D0 (en) Improved photobioreactor
GB201706621D0 (en) Biomarkers of barrett's esophagus
PT3377106T (en) Modulation of ciliogenesis
ZA201603748B (en) Direct reduction of diamminedichloropalladium (ii) salt
PT3377478T (en) Co-crystals of bilastine
GB201520382D0 (en) Sports aid
GB201518747D0 (en) Sports aid
AU365117S (en) Tongue Anteriorizor
GB201503465D0 (en) Sequencing methods
GB201700900D0 (en) Sequencer
GB201508547D0 (en) Sports aid

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed